Carleton RN, Norton MA, Asmundson GJ Fearing the unknown: a short version of the Intolerance of Uncertainty Scale. J Anxiety Disord. 2007;21(1):105-17. Epub 2006 May 2.
Carver CS, White TL Behavioural inhibition, behavioural activation, and affective responses to impending reward and punishment: The BIS/BAS scales. J Pers Soc Psychol, 67, 319-333, 1994.
Cattelani R, Zettin M, Zoccolotti P Rehabilitation treatments for adults with behavioral and psychosocial disorders following acquired brain injury: a systematic review. Neuropsychol Rev. 2010 Mar;20(1):52-85. doi: 10.1007/s11065-009-9125-y. Epub 2010 Feb 9. Review. Erratum in: Neuropsychol Rev. 2011 Jun;21(2):224.
Fazel S, Wolf A, Pillas D, Lichtenstein P, Långström N Suicide, fatal injuries, and other causes of premature mortality in patients with traumatic brain injury: a 41-year Swedish population study. JAMA Psychiatry. 2014 Mar;71(3):326-33. doi: 10.1001/jamapsychiatry.2013.3935.
Kanter JW, Mulick PS, Busch AM, et al The Behavioural Activation for Depression Scale (BADS): Psychometric properties and factor structure. J Psychopathol Behav 29(3), 191-202, 2007.
Lachman ME, Weaver SL Sociodemographic variations in the sense of control by domain: findings from the MacArthur studies of midlife. Psychol Aging. 1998 Dec;13(4):553-62.
Lachman ME, Weaver SL The sense of control as a moderator of social class differences in health and well-being. J Pers Soc Psychol. 1998 Mar;74(3):763-73.
Mazzucchelli T, Kane R, Rees CS Behavioural activation treatments for depression in adults: A meta-analysis and review. Clin Psychol-Sci Pr 16(4): 383-411, 2009.
Medley AR, Powell T Motivational Interviewing to promote self-awareness and engagement in rehabilitation following acquired brain injury: A conceptual review. Neuropsychol Rehabil. 2010 Aug;20(4):481-508. doi: 10.1080/09602010903529610. Epub 2010 Feb 1. Review.
Oddy M, Cattran C, Wood R The development of a measure of motivational changes following acquired brain injury. J Clin Exp Neuropsychol. 2008 Jul;30(5):568-75. doi: 10.1080/13803390701555598.
Turner-Stokes L Evidence for the effectiveness of multi-disciplinary rehabilitation following acquired brain injury: a synthesis of two systematic approaches. J Rehabil Med. 2008 Oct;40(9):691-701. doi: 10.2340/16501977-0265.
Waldron B, Casserly LM, O'Sullivan C Cognitive behavioural therapy for depression and anxiety in adults with acquired brain injury: what works for whom? Neuropsychol Rehabil. 2013;23(1):64-101. doi: 10.1080/09602011.2012.724196. Epub 2012 Nov 5. Review.
Whelan-Goodinson R, Ponsford J, Johnston L, Grant F Psychiatric disorders following traumatic brain injury: their nature and frequency. J Head Trauma Rehabil. 2009 Sep-Oct;24(5):324-32. doi: 10.1097/HTR.0b013e3181a712aa.
Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70.
Mood, Activity Participation, and Leisure Engagement Satisfaction (MAPLES): A Pilot Feasibility Study for Low Mood in Acquired Brain Injury
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
